🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦ 🎁 Contribute Documents & Earn Free Downloads ✦ Upload your notes, past papers & textbooks ✦ Share knowledge · Unlock resources for free ✦

NR 607 Week 1 Discussion; Involuntary Treatment - Complete Answers

Chamberlain University Nursing NR 607 Diagnosis & Management in Psychiatric-Mental Health III Practicum Albert Brooks 3 pages
View Full Course

Document Preview

Unlock Full 3 Page Document Instantly.

Document Overview

when risk is serious, the legal criteria are clearly met, voluntary strategies have been exhausted, and the ordered plan includes meaningful services rather than simply forced medication (Mental Health America, n.d.). III. In Maryland, clients who disagree with involuntary treatment decisions have several legal protections: they must receive a hearing within 10 days of initial confinement, they have the right to legal representation including a public defender if they cannot afford counsel, they may present witnesses and question opposing witnesses, and if the ALJ orders continued commitment, they may appeal within 30 days, seek habeas corpus, or petition for judicial release. For involuntary medication, Maryland also provides review and appeal processes through a clinical review panel and ALJ review, which reinforces that involuntary treatment decisions are not solely clinical decisions but legal decisions subject to due process (Chawla & Alam, 2024) IV. A situation that could create moral distress for me would be caring for a client who refuses treatment because of fear, trauma history, cultural mistrust, or poor prior experiences, while the clinical team believes involuntary treatment is necessary to prevent serious harm. The distress would come from balancing beneficence and safety against autonomy and possible retraumatization. Resources for providers include ethics consultation, clinical supervision, interdisciplinary case review, risk-management consultation, peer support, employee assistance programs, debriefing after high-stress events, and professional guidance from organizations such as APA and MHA (American Psychiatric Association, 2020). These supports help providers process conflict while maintaining ethical, legally defensible care (Valasek et al., 2025). V. My perspective would lead me to use involuntary psychiatric treatment only when absolutely necessary. I would prioritize voluntary engagement, careful risk assessment, thorough documentation, and the least restrictive treatment options. I view involuntary treatment as a last resort, appropriate only when a client poses a substantial risk and requires intensive support rather than coercion alone (Johnson et al., 2025). References American Psychiatric Association. (2020). Position statement on involuntary outpatient commitment and related programs of assisted outpatient treatment. https://www.psychiatry.org/getattachment/d50db97b-59aa-4dd4-a0ec-d09b4e19112e/Position- Involuntary-Outpatient-Commitment.pdf Chawla, M., & Alam, M. R. (2024). Clinical Review Panel - Policy & Procedure SGHC072293. Shady Grove Hospital Center (Clinical Review Panel). https://health.maryland.gov/springgrove/Policy/Hospital/Clinical%20Review%20Panel.pdf Johnson, K. L., Parish, W. J., Theis, E., Van Dorn, R. A., Callahan, L., Swanson, J. W., & Swartz, M. S. (2025). Clinical and Social Functioning Outcomes of Assisted Outpatient Treatment: Results from a Multisite Evaluation. Psychiatric research and clinical practice, 7(3), 174–181. https://doi.org/10.1176/appi.prcp.20240162

Full content available after purchase or with an active subscription.

Related Products

Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.